carbanucleoside analogues 4,7 via a stereoselective linchpin
cyclization reaction involving bis-epoxide 1 and dithianyl-
lithium 2. Bis-epoxide 1 is derived from arabitol in two
operations,8 and as the arabitol enantiomers are available at
similar cost, both D- and L-carbanucleoside derivatives would
be easily accessible.
Scheme 2. Mechanism of the Carbacyclization
Scheme 1. Synthesis Outline
would then be followed by 5-exo or 6-exo (7-endo)15
cyclization. Literature precedence for carbanionic cyclization
to δ-terminal epoxides suggest that the regioselectivity is
dependent on the metal ion, with lithiated species favoring
5-exo ring closure.16 Hence, the desired diastereomers 3R
and 3â were expected as main reaction products.
In the event, we were delighted to observe that reaction
of 2, obtained by tert-BuLi-mediated deprotonation of 2-tert-
butyldimethylsilyl-1,3-dithiane 9, with 1 proceeded as de-
picted above with high 5-exo selectivity (Table 1). The
double-addition product 11 was only formed in very small
amounts in all cases. As expected, a mixture of cyclopentane
diastereoisomers was formed, and 3â proved to be the major
diastereoisomer (see below).
Varying the temperature (entries 1-4) revealed -45 to
-18 °C to be the optimum temperature range for the yield
of 3 (entries 2-3). With increasing temperature, a decrease
in the diastereoselectivity 3â/3R was observed as well as an
increase in the formation of the six-membered cyclization
product 10.
Decreasing the concentration to 0.05 M led to an increased
yield of 3 (entry 5 vs 2). Reducing the concentration further
led to decreased yields of 3, but a greater amount of 1 was
recovered (entries 6 and 7). Replacing THF with Et2O as
solvent led to almost identical yields of 3, but an increased
selectivity toward 3â was observed (entry 8 vs 2). The
efficiency of carbacyclization was found to be significantly
hampered when the HMPA/THF ratio was reduced to 1:30
(entry 9).
When conducting the cyclization at -30 °C, a higher yield
was observed (entry 10 vs 7). In the end, addition of
molecular sieves led to a dramatic rise in the cyclization
yields (entries 11 vs 10, 12 vs 7). Increasing the HMPA/
THF ratio to 1:9 furnished a 77% yield of 3 (entry 13), and
the use of a slight excess of 2 completed the optimization in
which 3â and 3R were obtained in 80% combined yield (3.2:
1), together with 8% of 10 (entry 14). Increasing the
concentration further to 0.05 M did not lead to improved
results (entry 15).
The reaction of dithianyl anion with chiral epoxide
electrophiles enables the construction of partially protected
aldol linkages in a stereospecific manner.9 Fully protected
aldol linkages can be directly obtained by utilizing silylated
dithiane nucleophiles via a Brook rearrangement.10 The
rearrangement regenerates a dithianyl anion, which enables
subsequent transformations (see below).11 Judicious control
over the timing of the Brook rearrangement12 fully estab-
lished dithiane-based “linchpin” one-pot, multicomponent
coupling strategies for the construction of complex targets.13
This process has also been investigated with mannitol-derived
1,5-bis-epoxides14 to afford cyclohexane and cycloheptane
derivatives.
With 3-benzyl-1,2:4,5-dianhydroarabitol 1, it was envi-
sioned that the linchpin cyclization process would proceed
following the accepted mechanism as shown in Scheme 2.
Ring opening of one of the diastereotopic epoxide groups
by 2 would lead to a diastereoisomeric mixture of alkoxides
5/7. HMPA-promoted Brook rearrangement to give 6/8
(7) Synthesis of 6′-substituted nucleosides: (a) Yang, Y.-Y.; Meng, W.-
D.; Qing, F.-L. Org. Lett. 2004, 6, 4257. (b) Hong, J. H.; Oh, C.-H.; Cho,
J.-H. Tetrahedron 2003, 59, 6103. (c) Bianco, A.; Celletti, L.; Mazzei, R.
A.; Umani, F. Eur. J. Org. Chem. 2001, 1331. (d) Wachtmeister, J.; Classon,
B.; Samuelsson, B.; Kvarnstro¨m, I. Tetrahedron 1997, 53, 1861. (e) Bisacchi,
G. S.; Chao, S. T.; Bachard, C.; Daris, J. P.; Innaimo, S.; Jacobs, G. A.;
Kocy, O.; Lapointe, P.; Martel, A.; Merchant, Z.; Slusarchyk, W. A.;
Sundeen, J. E.; Young, M. G.; Colonno, R.; Zahler, R. Bioorg. Med. Chem.
Lett. 1997, 7, 127. (f) Tanaka, M.; Norimine, Y.; Fujita, T.; Suemune, H.;
Sakai, K. J. Org. Chem. 1996, 61, 6952. (g) Altmann, K.-H.; Kesselring,
R.; Pieles, U. Tetrahedron 1996, 52, 12699. (h) Katagiri, N.; Nomura, M.;
Sato, H.; Kaneko, C.; Yusa, K.; Tsuruo, T. J. Med. Chem. 1992, 35, 1882.
(8) (a) Dreyer, G. B.; Boehm, J. C.; Chenera, B.; DesJarlais, R. L.;
Hassell, A. M.; Meek, T. D.; Tomaszek, T. A., Jr.; Lewis, M. Biochemistry
1993, 32, 937. (b) Schreiber, S. L.; Sammakia, T.; Uehling, D. E. J. Org.
Chem. 1989, 54, 15. (c) Leung, L. M. H.; Gibson, V.; Linclau, B.
Tetrahedron: Asymmetry 2005, 16, 2449.
(9) Yus, M.; Na´jera, C.; Foubelo, F. Tetrahedron 2003, 59, 6147.
(10) (a) Moser, W. H. Tetrahedron 2001, 57, 2065. (b) Brook, A. G.
Acc. Chem. Res. 1974, 7, 77.
(11) (a) Shinokubo, H.; Miura, K.; Oshima, K.; Utimoto, K. Tetrahedron
Lett. 1993, 34, 1951. (b) Tietze, L. F.; Geissler, H.; Gewert, J. A.; Jakobi,
U. Synlett 1994, 511. (c) Fischer, M.-R.; Kirschning, A.; Michel, T.;
Schaumann, E. Angew. Chem., Int. Ed. Engl. 1994, 33, 217.
(12) Smith, A. B., III; Boldi, A. M. J. Am. Chem. Soc. 1997, 119, 6925
(13) (a) Smith, A. B., III; Pitram, S. M.; Boldi, A. M.; Gaunt, M. J.;
Sfouggatakis, C.; Moser, W. H. J. Am. Chem. Soc. 2003, 125, 14435. (b)
Smith, A. B., III; Adams, C. M. Acc. Chem. Res. 2004, 37, 365.
(14) (a) Le Merrer, Y.; Gravier-Pelletier, C.; Maton, W.; Numa, M.;
Depezay, J.-C. Synlett 1999, 1322. (b) Bra¨uer, N.; Dreessen, S.; Schaumann,
E. Tetrahedron Lett. 1999, 40, 2921.
(15) For nomenclature, see: Narayan, R. S.; Sivakumar, M.; Bouhlel,
E.; Borhan, B. Org. Lett. 2001, 3, 2489 and references therein.
(16) (a) Babler, J. H.; Bauta, W. E. Tetrahedron Lett. 1984, 25, 4323.
(b) Cooke, M. P., Jr.; Houpis, I. N. Tetrahedron Lett. 1985, 26, 3643. (c)
Rieke, R. D.; Wehmeyer, R. M.; Wu, T.-C.; Ebert, G. W. Tetrahedron 1989,
45, 443. (d) Fleming, I.; Mart´ınez de Marigorta, E. J. Chem. Soc., Perkin
Trans. 1 1999, 889.
5184
Org. Lett., Vol. 7, No. 23, 2005